Chronic Lymphocytic Leukaemia – Upfront Treatment

John Gribben | Onkologi /hematologi | desember 2, 2018

Speaker: John Gribben

CLL is an extremely heterogeneous disease, where most patients are now present with early stage disease and are asymptomatic, and some patients have an extremely indolent course and may never require treatment. In this MEDtalk professor John Gribben, Barts Cancer Institute, explains about upfront treatment for patient with CLL.